FDA
approval
· 2022-02-24
FDA Approved: NORLIQVA — Original Application (CMP Pharma, Inc.)
Summary
FDA approved NORLIQVA (amlodipine) from CMP Pharma as an original application. The product is indicated for the treatment of hypertension and angina pectoris.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for NORLIQVA (AMLODIPINE)